Oxford BioDynamics Plc (LON:OBD – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 0.21 and traded as low as GBX 0.20. Oxford BioDynamics shares last traded at GBX 0.20, with a volume of 554,075 shares.
Oxford BioDynamics Price Performance
The stock has a 50 day moving average of GBX 0.21 and a two-hundred day moving average of GBX 0.25. The company has a debt-to-equity ratio of 457.97, a quick ratio of 2.80 and a current ratio of 0.88. The firm has a market capitalization of £8.41 million, a P/E ratio of -0.25 and a beta of 0.42.
About Oxford BioDynamics
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Featured Articles
- Five stocks we like better than Oxford BioDynamics
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
